Kheiron Medical Technologies Company
Kheiron creates Artificial Intelligence (AI) solutions that really make a difference. By helping radiologists detect cancer earlier, its next-generation technology can increase chances of survival and pave the way for less invasive treatments.
Mia®, whose name comes from Mammography Intelligent Assessment, is Kheiron's breakthrough AI platform for breast screening.
Mia®, whose name comes from Mammography Intelligent Assessment, is Kheiron's breakthrough AI platform for breast screening.
Technology:
Diagnostics
Industry:
General Healthcare
Headquarters:
London, England, United Kingdom
Zip:
01-01-2016
Founded Date:
01-01-2016
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
19
Total Funding:
$22,322,058
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-08-01
Last Funding Type:
Convertible Note
Register and Claim Ownership